What's next for the hepatitis A vaccine?
- 1 February 2006
- journal article
- Published by Elsevier in The Lancet
- Vol. 367 (9510) , 546-548
- https://doi.org/10.1016/s0140-6736(06)68196-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Person-to-Person Transmission of Hepatitis A Virus in an Urban Area of Intermediate Endemicity: Implications for Vaccination StrategiesAmerican Journal of Epidemiology, 2005
- Incidence of Hepatitis A in Israel Following Universal Immunization of ToddlersJAMA, 2005
- Incidence of Hepatitis A in the United States in the Era of VaccinationJAMA, 2005
- Prevention of viral hepatitis in the Nordic countries and GermanyScandinavian Journal of Infectious Diseases, 2005
- Declining hepatitis A seroprevalence: a global review and analysisEpidemiology and Infection, 2004
- Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands)Vaccine, 2004
- Hepatitis A booster vaccination: is there a need?The Lancet, 2003
- Hepatitis A vaccination options for AustraliaJournal of Paediatrics and Child Health, 2003
- Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicityJournal of Hepatology, 2001
- Hepatitis A and B in children and adolescents – what can we learn from Puglia (Italy) and Catalonia (Spain)?Vaccine, 2000